SciSparc Files Annual Report for Year Ended December 31, 2021 and Provides Corporate Update
TEL AVIV, Israel, May 02, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on...
Day: May 2, 2022
Palisade Bio Provides Business Outlook and Highlights Expected Near-Term Pipeline Advancements
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on track to commence Q2 2022CARLSBAD, Calif.,...
Healthy Extracts’ First Major Brand Influencer Launches New Line of Natural Health and Fitness Formulations on WhitneyJohns.com
Whitney Johns Product Line The New Whitney Johns Product Line includes BRAIN ACTIVATE (in gel and powder form), ACTIVE for...
Alaunos Therapeutics Doses First Patient in TCR-T Library Phase 1/2 trial for the Treatment of Patients with Solid Tumors
First-in-human non-viral TCR-T cell therapy targeting shared hotspot mutations in solid cancersFirst clinical product manufactured and administered to a patient...
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System
SUNNYVALE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk...
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study
MIAMI, May 02, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today announced that the FDA has...
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
Partner Sanofi has commenced dosing in a Phase 2 clinical trial of SAR443820 (DNL788) in individuals with amyotrophic lateral sclerosis...
Galecto to Participate at Upcoming Investor Conferences
BOSTON, May 02, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development...
NKGen Biotech Announces Three SNK01 Abstracts to be Presented at the 2022 ASCO Annual Meeting
SANTA ANA, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech Inc., a biotechnology company harnessing the power of the...
Treace Secures Up to $150 Million in Debt Financing
PONTE VEDRA, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a...
TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)
Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering...
Option Care Health to Participate in Upcoming Investor Conference
BANNOCKBURN, Ill., May 02, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest...
Ring Therapeutics Announces Publication Highlighting In Vivo Delivery and Tropism of the First Synthesized Human Anelloviruses Using a Recombinant Genome
Synthesized anellovirus particles demonstrated tissue-specific delivery in vivoCAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences...
Xtant Medical Appoints Scott Neils as Chief Financial Officer
BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company...
Pennant Acquires Home Health Provider, Senior Living Real Estate Asset
EAGLE, Idaho, May 02, 2022 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant...
aTyr Pharma to Webcast Conference Call Reporting First Quarter 2022 Financial Results
Management to host conference call and webcast on May 9th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, May...
Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Preclinical data suggest that SZN-413 can simultaneously address retinal non-perfusion and leakage in blood vessels in retinal vascular diseasesSOUTH SAN...
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9
DUBLIN, Ireland, May 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines...
LifeMD to Announce First Quarter Financial Results and Host Conference Call on Friday, May 13
NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that...
Join the MS Community and Raise Awareness for MS this May
MS Society invites Canadians to participate in nationwide MS Awareness Month activities TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- For...
